Robert Lisicki - 18 Jan 2024 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol
CVKD
Transactions as of
18 Jan 2024
Transactions value $
$0
Form type
4
Filing time
19 Jan 2024, 19:41:08 UTC
Previous filing
08 Jan 2024
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +50K $0.00 50K 18 Jan 2024 Common Stock 50K $0.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025.

Remarks:

Exhibit 24 - Power of Attorney